Gaura Véronique, Lavisse Sonia, Payoux Pierre, Goldman Serge, Verny Christophe, Krystkowiak Pierre, Damier Philippe, Supiot Frédéric, Bachoud-Levi Anne-Catherine, Remy Philippe
Commissariat à l'Energie Atomique et aux Energies Alternatives, Département des Sciences du Vivant, Institut d'Imagerie Biomédicale, MIRCen, Fontenay-aux-Roses, France.
Centre National de la Recherche Scientifique (CNRS), Université Paris-Sud, Université Paris-Saclay, UMR 9199, Neurodegenerative Diseases Laboratory, Fontenay-aux-Roses, France.
JAMA Neurol. 2017 Sep 1;74(9):1088-1096. doi: 10.1001/jamaneurol.2017.1200.
Brain hypometabolism is associated with the clinical consequences of the degenerative process, but little is known about regional hypermetabolism, sometimes observed in the brain of patients with clinically manifest Huntington disease (HD). Studying the role of regional hypermetabolism is needed to better understand its interaction with the motor symptoms of the disease.
To investigate the association between brain hypometabolism and hypermetabolism with motor scores of patients with early HD.
DESIGN, SETTING, AND PARTICIPANTS: This study started in 2001, and analysis was completed in 2016. Sixty symptomatic patients with HD and 15 healthy age-matched control individuals underwent positron emission tomography to measure cerebral metabolism in this cross-sectional study. They also underwent the Unified Huntington's Disease Rating Scale motor test, and 2 subscores were extracted: (1) a hyperkinetic score, combining dystonia and chorea, and (2) a hypokinetic score, combining bradykinesia and rigidity.
Statistical parametric mapping software (SPM5) was used to identify all hypo- and hypermetabolic regions in patients with HD relative to control individuals. Correlation analyses (P < .001, uncorrected) between motor subscores and brain metabolic values were performed for regions with significant hypometabolism and hypermetabolism.
Among 60 patients with HD, 22 were women (36.7%), and the mean (SD) age was 44.6 (7.6) years. Of the 15 control individuals, 7 were women (46.7%), and the mean (SD) age was 42.2 (7.3) years. In statistical parametric mapping, striatal hypometabolism was significantly correlated with the severity of all motor scores. Hypermetabolism was negatively correlated only with hypokinetic scores in the cuneus (z score = 3.95, P < .001), the lingual gyrus (z score = 4.31, P < .001), and the crus I/II of the cerebellum (z score = 3.77, P < .001), a region connected to associative cortical areas. More severe motor scores were associated with higher metabolic values in the inferior parietal lobule, anterior cingulate, inferior temporal lobule, the dentate nucleus, and the cerebellar lobules IV/V, VI, and VIII bilaterally corresponding to the motor regions of the cerebellum (z score = 3.96 and 3.42 in right and left sides, respectively; P < .001).
Striatal hypometabolism is associated with clinical disease severity. Conversely, hypermetabolism is likely compensatory in regions where it is associated with decreasing motor scores. Hypermetabolism might be detrimental in other structures in which it is associated with more severe motor symptoms. In the cerebellum, both compensatory and detrimental contributions seem to occur. This study helps to better understand the motor clinical relevance of hypermetabolic brain regions in HD.
脑代谢减退与退行性病变的临床后果相关,但对于有时在临床症状明显的亨廷顿舞蹈病(HD)患者大脑中观察到的局部代谢亢进情况,人们了解甚少。研究局部代谢亢进的作用有助于更好地理解其与该疾病运动症状的相互作用。
研究早期HD患者脑代谢减退和代谢亢进与运动评分之间的关联。
设计、地点和参与者:本研究始于2001年,分析于2016年完成。在这项横断面研究中,60例有症状的HD患者和15名年龄匹配的健康对照者接受了正电子发射断层扫描以测量脑代谢。他们还接受了统一亨廷顿舞蹈病评定量表运动测试,并提取了两个子评分:(1)一个多动评分,包括肌张力障碍和舞蹈症;(2)一个少动评分,包括运动迟缓和平直度。
使用统计参数映射软件(SPM5)来识别HD患者相对于对照者的所有代谢减退和代谢亢进区域。对有显著代谢减退和代谢亢进的区域进行运动子评分与脑代谢值之间的相关性分析(P < 0.001,未校正)。
60例HD患者中,22例为女性(36.7%),平均(标准差)年龄为44.6(7.6)岁。15名对照者中,7例为女性(46.7%),平均(标准差)年龄为42.2(7.3)岁。在统计参数映射中,纹状体代谢减退与所有运动评分的严重程度显著相关。代谢亢进仅与楔叶(z值 = 3.95,P < 0.001)、舌回(z值 = 4.31,P < 0.001)和小脑脚I/II(z值 = 3.77,P < 0.001)的少动评分呈负相关,小脑脚I/II与联合皮质区域相连。更严重的运动评分与双侧顶下小叶、前扣带回、颞下小叶、齿状核以及与小脑运动区域相对应的小脑小叶IV/V、VI和VIII的更高代谢值相关(右侧和左侧的z值分别为3.96和3.42;P < 0.001)。
纹状体代谢减退与临床疾病严重程度相关。相反,代谢亢进在与运动评分降低相关的区域可能具有代偿作用。代谢亢进在与更严重运动症状相关的其他结构中可能有害。在小脑中,似乎既有代偿作用也有有害作用。这项研究有助于更好地理解HD中脑代谢亢进区域的运动临床相关性。